As of March 20, 2023, around 391 doses of COVID-19 vaccines per 100 people in Cuba had been administered, one of the highest COVID-19 vaccine dose rates of any country worldwide. This statistic shows the rate of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country or territory.

As of March 20, 2023, over 13 billion COVID-19 vaccine doses had been administered worldwide, with the United States accounting for almost 672 million of this total. This statistic shows the number of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country.

As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.

The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

As of August 13, 2024 most Latin American and Caribbean countries had started the COVID-19 vaccination process. While Brazil had administered around 486 million doses of the vaccine, Mexico had applied approximately 223 million doses. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

As of March 15, 2023, Africa administered a total of around 776 million doses of vaccine against the coronavirus (COVID-19). Egypt and Nigeria were the countries with the highest number of inoculations on the continent, while Seychelles and Mauritius recorded the highest vaccination rate per 100 people.

By August 2024, Cuba had administered the largest number of vaccines against COVID-19 per 100 inhabitants in the Latin American region, followed by Chile and Peru. According to recent estimates, the Caribbean country applied around 410 doses per 100 population, accounting for one of the largest vaccination rates observed not only in the Latin American region, but worldwide. In comparison, Haiti registered the lowest vaccination rate within the region, with only 5.87 doses administered per 100 inhabitants. Booster shots started To reinforce the immune protection against the fast spread of the SARS-CoV-2, governments began to introduce booster shots in their immunization programs aiming at strengthening people’s immune response against new contagious COVID-19 variants. In Latin America, Cuba was leading on booster shots relative to its population among a selection of countries, with around 88 percent of the population receiving the extra dose. In comparison, these numbers are higher than those for the European Union and the United States. Pharmaceutical research continues As Omicron becomes more prominent worldwide, and recombinant variants emerge, research efforts to prevent and control the disease continue to progress. As of June 2022, there were around 2,700 clinical trials to treat COVID-19 and 1,752 COVID-19 vaccines trials in clinical development. Other studies were focused on mild, moderate and severe COVID-19, complication support, and post-COVID symptoms, among others.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

As of September 2021, lower-middle-income countries had around 43 percent of the total world population, but only accounted for around 22 percent of COVID-19 vaccine doses administered globally. This statistic illustrates the percentage of COVID-19 vaccine doses administered worldwide as of September 10, 2021, by country income group.

As of March 9, 2021, India has secured some 2.2 billion COVID-19 vaccine doses through contracts in total. India chose to purchase vaccines manufactured by AstraZeneca (Oxford), Novavax, and the Russian Gamaleya Institute. However, the overwhelming majority of these doses have yet to be produced and delivered. This statistic shows the size of COVID-19 vaccine contracts based on number of doses secured by countries through contracts with manufacturers. The AstraZeneca/Oxford vaccine is by far the most sought COVID-19 vaccine, especially due to its ability to be stored at normal refrigerator temperatures, while other vaccines need ultra cold storage.

As of March 15, 2023, Seychelles was the African country with the highest coronavirus (COVID-19) vaccination rate, with around 205 doses administered per 100 individuals. Mauritius and Rwanda followed with 201 and 190 doses per 100 people, respectively. Ranking fourth, Morocco had a vaccination rate of approximately 148 doses per 100 people, registering the third-highest number of inoculations after Egypt and Nigeria. In South Africa, the most affected country on the continent, the vaccination rate instead reached around 64 per 100 population.

How did Africa obtain the vaccines?

Vaccines in Africa were obtained in different ways. African nations both purchased new doses and received them from other countries. At the beginning of the vaccination campaigns, donations came from all over the world, such as China, the United Arab Emirates, India, and Russia. The United Nations-led COVAX initiative provided Oxford/AstraZeneca and Pfizer/BioNTech doses to several African countries. Within this program, the continent received nearly 270 million doses as of January 2022. Moreover, the vaccination campaign has also been an occasion for intra-African solidarity. Senegal has, for instance, donated vaccines to the Gambia, while in January 2021, Algeria announced that it would have shared its supply with Tunisia.

COVID-19 impact on the African economy

The spread of COVID-19 negatively affected socio-economic growth in Africa, with the continent’s Gross Domestic Product (GDP) contracting significantly in 2020. Specifically, Southern Africa experienced the sharpest decline, at minus six percent, followed by North Africa at minus 1.7 percent. Most of Africa’s key economic sectors were hit by the pandemic. The drop in global oil prices led to a crisis in the oil and gas sector. Nigeria, the continent’s leading oil-exporting country, witnessed a considerable decrease in crude oil trade in 2020. Moreover, the shrinking number of international tourist arrivals determined a loss of over 12 million jobs in Africa’s travel and tourism sector. Society has also been substantially affected by COVID-19 on the poorest continent in the world, and the number of people living in extreme poverty was estimated to increase by around 30 million in 2020.

As of October 5, 2023, Austria had received 583.7 vaccine doses per 100 adults from COVID-19 vaccine manufacturers, the highest delivery rate among all EEA states. Hungary was the first in the EEA to receive distribution of vaccines from Sinopharm and Sputnik V, and has received 340.6 doses per 100 population. Latvia had received 489.5 COVID-19 vaccine doses per 100 population, while so far Romania had received 140.2 doses per 100 inhabitants. The current rate of COVID-19 vaccines administered in Europe can be found here. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

As of June 30, 2023, Japan has administered around 310 doses of COVID-19 vaccine per 100 people, the highest in the Asia-Pacific region. In comparison, Papua New Guinea has administered only approximately 7.27 COVID-19 vaccine doses per 100 people.

As of July 21, 2022, most countries in the European Economic Area (EEA) had received the majority of their COVID-19 vaccine stock from Comirnaty (Pfizer/BioNTech). In Denmark, the Comirnaty vaccine accounted for 83 percent of the total COVID-19 vaccines distributed to the country. Hungary was the first country in the EEA to have received COVID-19 vaccines from Sinopharm and Sputnik V which were developed in China and Russia respectively. The current rate of COVID-19 vaccines administered in Europe can be found here. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

Russia was to export 250 million doses of the coronavirus (COVID-19) vaccine Sputnik V to India, which was among the major planned producers of the vaccine. In total, Indian companies planned to produce at least 1,152 million doses of Sputnik V per year. Furthermore, Mexico ordered a total of 24 million doses of the vaccine. Sputnik V was authorized in more than 70 countries worldwide as of January 2022. Russia applied for the vaccine approval in the European Union in January 2021, while several EU countries approved its use earlier, such as Hungary or Slovakia.

Russia's first vaccine against COVID-19 In August 2020, Russia registered Sputnik V, the world’s first approved vaccine against COVID-19, which was developed at Gamaleya Research Institute in Moscow. After the third phase of clinical trials, the vaccine's effectiveness was measured at 91.6 percent. The mass vaccination in Russia started in January 2021. In December 2020, 30 percent of Russians would get vaccinated against COVID-19 with Sputnik V.
Is Sputnik V available abroad? In total, over 50 countries worldwide placed orders for Sputnik V from Russia. As of January 2021, The vaccine was used for vaccination in Russia, Belarus, Serbia. In October 2020, Russia applied for prequalification of Sputnik V at the WHO to speed up its availability worldwide. Other countries that would produce the vaccine, such as Brazil, China, India, or the Republic of Korea, would also sell it abroad. Among several countries surveyed in November 2020, the highest level of awareness about Sputnik V was recorded in Mexico.

As of the end of March 9, 2021, India has secured a total of some 2.2 billion COVID-19 vaccine doses through contracts. The European Union made pre-purchase agreements for nearly 1.84 billion doses in total with various manufacturers. This statistic shows the size of COVID-19 vaccine contracts based on total number of doses secured by countries. However, the overwhelming majority of these doses have yet to be produced and delivered.

As of December 23, 2022, around 80 percent of the population of the United States had been given at least one dose of a COVID-19 vaccination. This statistic shows the percentage of population in select countries and territories worldwide that had received a COVID-19 vaccination as of December 23, 2022.

The United Arab Emirates (UAE) had the highest number of COVID-19 vaccine doses administered at about 134.63 doses per 100 people in June 2021 among other Gulf Cooperation Council (GCC) countries. Among other Gulf Cooperation Council (GCC) countries, Qatar was the only country with a positive fiscal balance before the COVID-19 pandemic.

As of June 2023, among Asia-Pacific countries, China had administered the highest number of coronavirus (COVID-19) vaccine doses, amounting to 1.31 billion. This was followed by India with a value of 1.03 billion doses in June 2023.

As at January 2021, Bangladesh had received two million doses of the AstraZeneca vaccine produced by the Serum Institute of India. India is one of the biggest producers of the vaccine worldwide. On January 20, the government of India launched its "Vaccine Maitri" (Vaccine Friendship) initiative to support its neighboring countries as well as countries with a significant number of Indian citizens.

By August 2021, Romania donated over one million AstraZeneca vaccine doses to countries such as Serbia, Ukraine, Tunisia, Vietnam, and Egypt. At the same time, Romania sold 1,170,000 Pfizer vaccines to Denmark.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

As of June 7, 2022, China had administered almost 3.4 billion doses of COVID-19 vaccines, representing around 28 percent of the 11.9 billion doses administered worldwide.

Vaccination rate

China has one of the highest COVID-19 vaccination rates in the world. Nevertheless, the situation varies substantially between age groups. Unlike many other regions such as Japan and western Europe, the Chinese elderly population has a lower vaccination rate than the younger generations. As of March 2022, only around half of people aged above 80 were fully vaccinated in the country, while less than 20 percent had their booster vaccinations.

The insufficient vaccination rate among the most vulnerable group of the society partially explains China’s “Zero COVID” strategy, as many fear that the healthcare service will not be able to cope with the spread of COVID-19.

Chinese vaccines

As a major partner and stakeholder of BioNTech, the German developer of Comirnaty, Chinese pharmaceutical firm Fosun Pharma secured 100 million doses of mRNA COVID-19 vaccines in the early days of the pandemic. Nevertheless, no mRNA vaccine received approval from the Chinese regulator and the majority of the doses secured by Fosun remained undelivered.

Sinovac and Sinopharm’s vaccines, the two most common COVID-19 vaccines in China, are both inactivated whole virus vaccines, which stimulate immune responses with killed SARS-CoV-2 virus. Despite having many advantages, they are significantly less effective than mRNA vaccines in preventing symptomatic illness and are especially problematic when encountering the latest Omicron variant of SARS-CoV-2.